Previous close | 201.54 |
Open | 201.28 |
Bid | 82.61 x 1300 |
Ask | 204.39 x 800 |
Day's range | 200.45 - 204.63 |
52-week range | 185.22 - 254.00 |
Volume | |
Avg. volume | 488,947 |
Market cap | 20.148B |
Beta (5Y monthly) | 0.79 |
PE ratio (TTM) | 35.83 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 2.08 (1.02%) |
Ex-dividend date | 22 Feb 2024 |
1y target est | N/A |
DUBLIN, IRELAND, April 24, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2024 fourth quarter and full year financial results at 9:00 a.m. ET on May 9, 2024. The conference call can be heard live at www.steris-ir.com or via phone by dialing 1-833-535-2199 in the United States or 1-412-902-6776 internationally, then asking to join the conference call for STERIS plc. A press release detailing fin
An affiliate of Peak Rock Capital ("Peak Rock"), a leading middle-market private equity firm, announced today that it has signed a definitive agreement to acquire the dental segment ("HuFriedyGroup" or the "Company") of STERIS plc (NYSE:STE) ("STERIS").
Transaction expected to close in STERIS’s first quarter of fiscal 2025Divestiture allows STERIS to focus on Customers within core marketsProceeds primarily to be used to repay debt DUBLIN, IRELAND, April 11, 2024 (GLOBE NEWSWIRE) -- ) - STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced that the Company has entered into a definitive agreement to divest its Dental segment to Peak Rock Capital, a leading middle-market private investment firm, for $787.5 million (the “Transaction”).